Company will be seeking alignment to begin rolling BLA submission NEW YORK--(BUSINESS WIRE)-- OS Therapies (OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback